MEDITE Cancer Diagnostics Inc (MDIT) ,Medical Equipment Deals 2017 Analysis by Growth,Type,Market segments,Key Deals & Region

HTF Market Intelligence released a new research report of 19 pages on title ‘MEDITE Cancer Diagnostics Inc (MDIT) – Medical Equipment – Deals and Alliances Profile’  with detailed analysis, forecast and strategies.

Summary

MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, robotic coverslippers, and cytology screening systems. The company products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. The company is headquartered in Orlando, the US.

Report Highlights

MEDITE Cancer Diagnostics Inc (MDIT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary researc.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description – A brief description of the company’s operations.

- Key Employees – A list of the key executives of the company.

- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors – A list of the key competitors of the company.

- Key Recent Developments – A brief on recent news about the company.

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=374261

Table of Contents 

Table of Contents  2

List of Tables  3

List of Figures  4

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017  5

MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017  6

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017  7

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017  8

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017  9

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deal Details  10

Venture Financing  10

MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing  10

MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing  10

Partnerships  11

Medite To Enter Into Licensing Agreement With Unic Technologies  11

Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film  12

Equity Offering  12

CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million  12

Acquisition  13

CytoCore Completes Acquisition Of Medite  13

MEDITE Cancer Diagnostics Inc – Key Competitors  15

Key Employees  16

Locations And Subsidiaries  17

Head Office  17

Other Locations & Subsidiaries  17

Recent Developments  18

Corporate Communications  18

Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors  18

Appendix  19

Methodology  19

About GlobalData  19

Contact Us  19

Disclaimer  19List of Tables 

MEDITE Cancer Diagnostics Inc, Medical Equipment, Key Facts, 2015  1

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017  1

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017  5

MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017  6

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017  7

MEDITE Cancer Diagnostics Inc, Deals By Market, 2011 to YTD 2017  8

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017  9

MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing  10

MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing  10

Medite To Enter Into Licensing Agreement With Unic Technologies  11

Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film  12

CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million  12

CytoCore Completes Acquisition Of Medite  13

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements

- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy

- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

ormation on the company’s recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/374261-medite-cancer-diagnostics-inc-2

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

[email protected]

Ph: +1 (206) 317 1218